Analysts do see a lift to its sales, even as some of them are not factoring in sales beyond FY23 amid uncertainty over booster shots. The p...

Cadila Healthcare is a largecap company, operating in pharmaceuticals and health care sector.

Better than expected sales and net profit growth, limited impact of US FDA due to its limited exposure, and among other things, have made i...

"What is 'closed' is the initial review that resulted in the warning letter issuance," Cadila Healthcare said.

Gaurav Bissa of LKP Securities recommends buy rating on Cadila Healthcare with a target of Rs 350 and a strict stop loss of Rs 310

The company's board, which met today, decided to delist equity shares of the company from ASE, Cadila Healthcare said in a filing to the BS...

Shares of Cadila Healthcare today surged nearly 6 per cent after pharma firm reported 81.54 per cent increase in consolidated net profit fo...

India's fifth largest drug maker by revenue, Zydus Cadila Group has settled a patent litigation with US-based Warner Chilcott Company LLC.

In 2000, Zydus Cadila had created a strategic alliance with Ambalal Sarabhai Enterprises to integrate the animal healthcare business of bot...

Investors should align themselves with businesses which are export oriented, and with companies which will benefit if rupee depreciates.

The estimated sales in 2012 as per IMS for Doxepin Hcl, which falls in the neuropsychiatry segment, was $15.5 million, as per company.

According to pharma analyst, the company would continue to witness jump in its stock prices as it is bullish on getting FDA approval for it...

It's a stock which creates alpha, meaning regardless of market movement, it generally tends to move on the upside.

Cadila Healthcare said it has launched generic Pramipexole tablets, used for treating Parkinson's disease, in the US market.

The Delhi High Court has turned down the plea of drug firm Cadila healthcare seeking to restrain Diat Foods from using the 'sugar free' tag...

Deepak Mohoni, director, trendwatchindia.com, in a chat with ET Now talks about the pharma stocks.

Pharmaceutical firm Cadila Healthcare said its shareholders have approved the restructuring of its consumer products division as subsidiary...